Bioactive chitosan/polydopamine nanospheres coating on carbon fiber towards strengthening epoxy composites
Qing Wu,
No information about this author
Bolin Xiao,
No information about this author
Yating Li
No information about this author
et al.
International Journal of Biological Macromolecules,
Journal Year:
2024,
Volume and Issue:
275, P. 133568 - 133568
Published: July 3, 2024
Language: Английский
Near-Infrared Multifunctional Antitumor Nanomaterial of Bismuth Sulfide Heterojunction Coupled with Mesoporous Polydopamine
Juanxuan Guo,
No information about this author
Biling Chen,
No information about this author
Menglong Zhao
No information about this author
et al.
ACS Applied Bio Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 8, 2025
Bismuth
sulfide@bismuth
nanorods
(Bi2S3@Bi
NRs)
have
emerged
as
promising
photodynamic
therapeutic
agents
due
to
Bi2S3@Bi
being
able
produce
reactive
oxygen
species
from
self-supplied
O2.
Combining
photothermal
and
therapies
with
chemotherapy
is
attractive
but
difficult
achieve.
Here,
we
develop
a
subtle
method
wrap
NRs
mesoporous
polydopamine,
where
drug
doxorubicin
hydrochloride
can
be
loaded,
thus
providing
multifunctional
antitumor
nanospheres.
To
our
delight,
the
prepared
triple-functional
material
exhibits
excellent
efficacy
toward
tumor
cells
under
near-infrared
light
irradiation.
This
nanomaterial
not
only
biocompatible
also
suitable
for
hypoxic
microenvironments,
having
much
better
than
single-
or
double-functional
materials.
study
highlights
great
potential
of
combining
photothermal,
photodynamic,
chemotherapies.
Language: Английский
Tannic acid/doxorubicin hybrid nano-assemblies decorated with D-α-tocopheryl polyethylene glycol succinate-conjugated pemetrexed to treat non-small cell lung cancer
Wei-Jen Huang,
No information about this author
Wen‐Hsuan Chiang,
No information about this author
Hsiang-Yun Chih
No information about this author
et al.
Journal of the Taiwan Institute of Chemical Engineers,
Journal Year:
2025,
Volume and Issue:
172, P. 106115 - 106115
Published: April 8, 2025
Language: Английский
Enhanced Intracellular IR780 Delivery by Acidity-Triggered PEG-Detachable Hybrid Nanoparticles to Augment Photodynamic and Photothermal Combination Therapy for Melanoma Treatment
Min‐Chen Tsai,
No information about this author
L. T. Hsiao,
No information about this author
Yen-Hsuan Chang
No information about this author
et al.
ACS Applied Bio Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 12, 2025
The
PEGylation
of
drug-carrying
nanoparticles
has
often
been
used
to
prolong
blood
circulation
and
improve
drug
deposition
at
tumor
sites.
Nevertheless,
the
PEG-rich
hydrophilic
surfaces
retard
release
payloads
internalization
therapeutic
by
cancer
cells,
thus
lowering
anticancer
efficacy.
To
boost
potency
combined
photodynamic
therapy
(PDT)
photothermal
(PTT)
against
melanoma
conquering
PEG
dilemma,
herein,
hybrid
PEGylated
chitosan-covered
polydopamine
(PDA)
(PCPNs)
with
acidity-elicited
detachment
ability
were
fabricated
as
carriers
IR780,
a
small-molecule
photosensitizer
for
PTT
PDT.
IR780@PCPNs
displayed
uniform,
solid-like
spherical
shape
sound
colloidal
stability.
Under
near-infrared
(NIR)
irradiation,
showed
prominent
conversion
efficiency
(ca.
54.6%),
robust
stability,
reduced
IR780
photobleaching,
sufficient
singlet
oxygen
(1O2)
production,
glutathione-depleting
ability.
Moreover,
environmental
pH
being
from
7.4
5.0
37
°C,
decreased
interactions
between
PCPNs
due
increased
protonation
phenolic
hydroxyl
residues
within
PDA
primary
amine
groups
chitosan
accelerated
species
IR780@PCPNs.
Importantly,
cellular
uptake
B16F10
was
remarkably
promoted
in
weakly
acidic
milieu
upon
driven
disintegration
acid-labile
benzoic
imine.
With
NIR
internalized
generated
hyperthermia
1O2
damage
mitochondria,
thereby
effectively
inhibiting
proliferation
cells.
Collectively,
our
findings
present
practical
strategy
amplifying
efficacy
PDT
using
PEG-detachable
Language: Английский
Construction of CuS/HKUST-1@PDA drug carrier for enhanced chemo-photothermal synergistic therapy triggered by near-infrared light in tumor treatment
Peixuan Zou,
No information about this author
Yusong Pan,
No information about this author
Wenjie Luo
No information about this author
et al.
Colloids and Surfaces B Biointerfaces,
Journal Year:
2025,
Volume and Issue:
unknown, P. 114784 - 114784
Published: May 1, 2025
Language: Английский
RGD peptide-conjugated polydopamine nanoparticles loaded with doxorubicin for combined chemotherapy and photothermal therapy in thyroid cancer
Donglan Yuan,
No information about this author
Zhiqiang Lu,
No information about this author
Xin-Rong Xu
No information about this author
et al.
Discover Oncology,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Dec. 18, 2024
To
construct
polydopamine
(PDA)-based
nanoparticles
(NPs)
for
combined
chemotherapy
(CT)
and
photothermal
therapy
(PTT)
of
thyroid
tumors
by
conjugating
doxorubicin
(DOX)
via
Schiff
base
reaction
decorating
with
RGD
peptide.
Language: Английский
A pH-Responsive Ti-Based Local Drug Delivery System for Osteosarcoma Therapy
Journal of Functional Biomaterials,
Journal Year:
2024,
Volume and Issue:
15(10), P. 312 - 312
Published: Oct. 21, 2024
Osteosarcoma
is
one
of
the
major
bone
cancers,
especially
for
youngsters.
The
current
treatment
usually
requires
systemic
chemotherapy
and
removal
tumors.
Titanium
(Ti)-based
implants
can
be
modified
as
local
drug
delivery
(LDD)
systems
controllable
localized
chemotherapeutic
release.
In
this
work,
a
pH-responsive
Ti-based
LDD
prototype
was
designed
by
introducing
polydopamine
(PDA)
to
release
doxorubicin
(DOX)
around
osteosarcoma
cells
with
low
pH.
Fourier
transform
infrared
spectroscopy
(FTIR),
scanning
electron
microscopy
(SEM),
contact
angle
meter
were
applied
surface
characterization.
Both
direct
indirect
cell
culture
modes
performed
biocompatibility
biofunction
assessments.
results
indicate
that
exhibits
significant
pH-dependent
DOX
cumulative
reach
up
approximately
40%
at
pH
=
6.0
after
72
h,
but
only
20%
7.4.
implant
shows
good
93%
viability
MC3T3
in
vitro
24
h.
verify
anti-osteosarcoma
function
implant,
which
should
attributed
DOX.
Language: Английский